05B4 Birbe, Ruth - Jefferson Medical College - Thomas Jefferson University
rcb102

Ruth Birbe, MD

Contact Dr. Birbe

132 S. 10th St.
Main Building, Suite 285A
Philadelphia, PA 19107

(215) 955-2494
(215) 923-1969 fax

Most Recent Peer-reviewed Publications

  1. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: Implications for breast cancer prevention with antioxidant therapies
  2. Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis, via glycolysis and ketone production
  3. Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks?
  4. Mitochondrial metabolism in cancer metastasis: Visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue
  5. Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolism
  6. Pyruvate kinase expression (PKM1 and PKM2) in cancer associated fibroblasts drives stromal nutrient production and tumor growth
  7. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: Visualizing the therapeutic effects of metformin in tumor tissue
  8. Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis
  9. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts
  10. Lineage-specific T-cell responses to Cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease
  11. Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity
  12. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer
  13. Bile Acids Induce Ectopic Expression of Intestinal Guanylyl Cyclase C Through Nuclear Factor-κB and Cdx2 in Human Esophageal Cells
  14. So-called inflammatory myofibroblastic tumour: A proliferative lesion of fibroblastic reticulum cells?
  15. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: Therapeutic implications through protein modeling
  16. Rosai-Dorfman disease in a patient with systemic lupus erythematosus
  17. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract
  18. Gliosarcoma arising from an anaplastic ependymoma: A case report of a rare entity
  19. Glucagonlike Peptide-2 Analogue: A Possible New Approach in the Management of Inflammatory Bowel Disease
  20. Hepatocyte Growth Factor Treatment Ameliorates Diarrhea and Bowel Inflammation in a Rat Model of Inflammatory Bowel Disease
0